Determination of cytokine profile and associated genes of the signaling pathway in HNSCC

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics. 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a Cancer Journal for Clinicians, CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Brakenhoff RH, Leemans CR. Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. Ann Oncol. 2012;23(Suppl 10):x173–x177.
   PubMedGoogle Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Kim SH, Koo BS, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer. 2007;120(7):1418–1425.
   PubMed Web of Science ®Google Scholar
• Ha PK, Chang SS, Glazer CA, et al. Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol. 2009;45(4–5):335–339.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269–282.
   PubMed Web of Science ®Google Scholar
• Rakesh K, Agrawal DK. Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol. 2005;70(5):649–657.
   PubMed Web of Science ®Google Scholar
• Kalayci Yigin A, Cora T, Acar H, et al. Selection of reliable reference genes for qRT-PCR analysis on head and neck squamous cell carcinomas. Biomed Res. 2017;28(5):2014–2018.
   Google Scholar
• Worsham MJ, Chen KM, Meduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132(6):668–677.
   PubMedGoogle Scholar
• Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550–4559.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612–619.
   PubMed Web of Science ®Google Scholar
• Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.
   PubMed Web of Science ®Google Scholar
• Bhat AA, Yousuf P, Wani NA, et al. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Sig Transduct Target Ther. 2021;6(1):12.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Zouhair A, Azria D, et al. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol. 2006;1:11.
   PubMed Web of Science ®Google Scholar
• 16. Hoxhaj G, Manning BD. The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74–88.
   PubMed Web of Science ®Google Scholar
• Kalfert D, Ludvikova M, Topolcan O, et al. Serum levels of IGF-1 and IGFBP-3 in relation to clinical and pathobiological aspects of head and neck squamous cell carcinomas. Anticancer Res. 2017;37(6):3281–3286.
   PubMed Web of Science ®Google Scholar
• Montag M, Dyckhoff G, Lohr J, et al. Angiogenic growth factors in tissue homogenates of HNSCC: expression pattern, prognostic relevance, and interrelationships. Cancer Sci. 2009;100(7):1210–1218.
   PubMed Web of Science ®Google Scholar
• Feng X, Lin J, Xing S, et al. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma. BMC Cancer. 2017;17(1):90.
   PubMedGoogle Scholar
• Paulsson J, Ehnman M, Östman A. PDGF receptors in tumor biology: prognostic and predictive potential. Future Oncol. 2014;10(9):1695–1708.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22(10):1276–1312.
   PubMed Web of Science ®Google Scholar
• Conley-LaComb MK, Huang W, Wang S, et al. PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer. Am J Pathol. 2012;180(3):1017–1027.
   PubMed Web of Science ®Google Scholar
• Lin LH, Lin JS, Yang CC, et al. Overexpression of platelet-derived growth factor and ıts receptor are correlated with oral tumorigenesis and poor prognosis in oral squamous cell carcinoma. IJMS. 2020;21(7):2360.
   Google Scholar
• Gao Y, Katki H, Graubard B, et al. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Int J Cancer. 2012;131(2):E105–E113.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Z, Liang Z, et al. Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer. Onco Targets Ther. 2013;6:1437–1444.
   PubMed Web of Science ®Google Scholar
• Brahmkhatri VP, Prasanna C, Atreya HS. Insulin-like growth factor system in cancer: novel targeted therapies. Biomed Res Int. 2015;2015:538019.
   PubMed Web of Science ®Google Scholar
• Chung CH, Germain A, Subramaniam RM, et al. Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma. Head Neck. 2017;39(1):E15–E19.
   PubMed Web of Science ®Google Scholar
• Bossi P, Resteghini C, Paielli N, et al. Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. Oncotarget. 2016;7(45):74362–74379.
   PubMedGoogle Scholar
• Stommel JM, Kimmelman AC, Ying H, et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science. 2007;318(5848):287–290.
   PubMed Web of Science ®Google Scholar
• Allen GW, Saba C, Armstrong EA, et al. Insulin-like growth factor-I receptor signaling blockade combined with radiation. Cancer Res. 2007;67(3):1155–1162.
   PubMed Web of Science ®Google Scholar